human | Q5 |
P2038 | ResearchGate profile ID | Peter-Schuermann |
P1153 | Scopus author ID | 57209075563 |
P108 | employer | Hannover Medical School | Q911561 |
P106 | occupation | researcher | Q1650915 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q64948510 | A Splice Site Variant of CDK12 and Breast Cancer in Three Eurasian Populations. |
Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
Q39198367 | Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe |
Q44712404 | Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy |
Q47195947 | Assessment of a FBXW8 frameshift mutation, c.1312_1313delGT, in breast cancer patients and controls from Central Europe |
Q40381692 | Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
Q62583329 | Association of chromosomal locus 8q24 and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy |
Q96680596 | Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
Q34793437 | CYP2B6*6 is associated with increased breast cancer risk |
Q40756048 | Candidate gene variants of the immune system and sudden infant death syndrome. |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
Q90931747 | Evidence for an association of interferon gene variants with sudden infant death syndrome |
Q47549687 | Exome sequencing and case-control analyses identify RCC1 as a candidate breast cancer susceptibility gene |
Q91389910 | Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39 |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q101133544 | Genetic association study of fatal pulmonary embolism |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
Q34158129 | Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome |
Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q40285577 | Limited role of interferon-kappa (IFNK) truncating mutations in common variable immunodeficiency |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q30491647 | Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium |
Q34460831 | Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer |
Q37499453 | Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer |
Q62583334 | NBS1 variant I171V and breast cancer risk |
Q51908335 | Neuregulin-1 high-producer genotype is associated with a decreased risk of admission to the neonatal intensive care unit. |
Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
Q43773075 | Nijmegen Breakage Syndrome mutations and risk of breast cancer |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q40728414 | Rare ATAD5 missense variants in breast and ovarian cancer patients |
Search more.